Richard Close
Stock Analyst at Canaccord Genuity
(4.53)
# 1,038
Out of 5,051 analysts
656
Total ratings
48%
Success rate
9.4%
Average return
Main Sectors:
Stocks Rated by Richard Close
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLOV Clover Health Investments | Maintained: Buy | $5.5 | $4.58 | +20.09% | 32 | Oct 9, 2026 | |
| PGNY Progyny | Reiterated: Buy | $35 | $27.83 | +25.76% | 23 | Oct 8, 2026 | |
| HSTM HealthStream | Reiterated: Hold | $29 | $32.47 | -10.69% | 65 | Sep 16, 2026 | |
| WAY Waystar Holding | Reiterated: Buy | $33 | $26.48 | +24.62% | 13 | Sep 16, 2026 | |
| OMDA Omada Health | Reiterated: Buy | $28 | $20.82 | +34.49% | 13 | Sep 11, 2026 | |
| AHCO AdaptHealth | Reiterated: Buy | $10 | $6.07 | +64.88% | 32 | Sep 9, 2026 | |
| HCAT Health Catalyst | Reiterated: Hold | $1.8 | $1.75 | +2.86% | 35 | Sep 9, 2026 | |
| LFST LifeStance Health Group | Reiterated: Buy | $13 → $15 | $12.06 | +24.38% | 11 | Sep 9, 2026 | |
| PHR Phreesia | Reiterated: Buy | $16 | $10.66 | +50.09% | 25 | Sep 3, 2026 | |
| TDOC Teladoc Health | Reiterated: Buy | $10 | $5.54 | +80.51% | 78 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $0.3387 | +195.25% | 21 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $37 → $43 | $24.33 | +76.74% | 4 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $3.96 | +51.52% | 80 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 → $36 | $29.38 | +22.53% | 28 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $32 | $20.19 | +58.49% | 26 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $105 | $98.00 | +7.14% | 14 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $13 | $0.0001 | n/a | 6 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $110 | $145.70 | n/a | 1 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.5 → $2 | $0.0001 | n/a | 28 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $89 → $83 | $58.77 | n/a | 45 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $21 | $5.00 | n/a | 60 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $24 | $31.05 | n/a | 12 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $33 | $38.66 | n/a | 1 | Feb 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 | $227.80 | n/a | 1 | Mar 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $238.96 | n/a | 1 | Nov 18, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $20 | $9.15 | n/a | 1 | Nov 23, 2009 |
Clover Health Investments
Oct 9, 2026
Maintained: Buy
Price Target: $5.5
Current: $4.58
Upside: +20.09%
Progyny
Oct 8, 2026
Reiterated: Buy
Price Target: $35
Current: $27.83
Upside: +25.76%
HealthStream
Sep 16, 2026
Reiterated: Hold
Price Target: $29
Current: $32.47
Upside: -10.69%
Waystar Holding
Sep 16, 2026
Reiterated: Buy
Price Target: $33
Current: $26.48
Upside: +24.62%
Omada Health
Sep 11, 2026
Reiterated: Buy
Price Target: $28
Current: $20.82
Upside: +34.49%
AdaptHealth
Sep 9, 2026
Reiterated: Buy
Price Target: $10
Current: $6.07
Upside: +64.88%
Health Catalyst
Sep 9, 2026
Reiterated: Hold
Price Target: $1.8
Current: $1.75
Upside: +2.86%
LifeStance Health Group
Sep 9, 2026
Reiterated: Buy
Price Target: $13 → $15
Current: $12.06
Upside: +24.38%
Phreesia
Sep 3, 2026
Reiterated: Buy
Price Target: $16
Current: $10.66
Upside: +50.09%
Teladoc Health
Aug 31, 2026
Reiterated: Buy
Price Target: $10
Current: $5.54
Upside: +80.51%
Aug 18, 2026
Reiterated: Hold
Price Target: $1
Current: $0.3387
Upside: +195.25%
Aug 10, 2026
Rated: Buy
Price Target: $37 → $43
Current: $24.33
Upside: +76.74%
Aug 10, 2026
Reiterated: Buy
Price Target: $7 → $6
Current: $3.96
Upside: +51.52%
Aug 7, 2026
Rated: Buy
Price Target: $30 → $36
Current: $29.38
Upside: +22.53%
Aug 7, 2026
Reiterated: Buy
Price Target: $34 → $32
Current: $20.19
Upside: +58.49%
Aug 5, 2026
Reiterated: Buy
Price Target: $100 → $105
Current: $98.00
Upside: +7.14%
Mar 10, 2023
Reiterated: Buy
Price Target: $50 → $13
Current: $0.0001
Upside: n/a
Feb 27, 2023
Reiterated: Hold
Price Target: $110
Current: $145.70
Upside: n/a
May 12, 2022
Reiterated: Hold
Price Target: $2.5 → $2
Current: $0.0001
Upside: n/a
Nov 19, 2021
Reiterated: Hold
Price Target: $89 → $83
Current: $58.77
Upside: n/a
Nov 8, 2021
Reiterated: Buy
Price Target: $18 → $21
Current: $5.00
Upside: n/a
Aug 4, 2021
Reiterated: Buy
Price Target: $22 → $24
Current: $31.05
Upside: n/a
Feb 22, 2019
Reiterated: Hold
Price Target: $33
Current: $38.66
Upside: n/a
Mar 1, 2018
Reiterated: Buy
Price Target: $135
Current: $227.80
Upside: n/a
Nov 18, 2010
Reiterated: Hold
Price Target: n/a
Current: $238.96
Upside: n/a
Nov 23, 2009
Upgraded: Hold
Price Target: $20
Current: $9.15
Upside: n/a